We are live on ! Find out more
CIA

Capital Impact Advisors Portfolio holdings

AUM $247M
1-Year Est. Return 31.15%
This Fund
S&P 500
This Quarter Est. Return
+12.77%
1 Year Est. Return
+31.15%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$81.5M
AUM Growth
-$20.8M
Cap. Flow
-$26.6M
Cap. Flow %
-32.64%
Top 10 Hldgs %
12.33%
Holding
250
New
14
Increased
52
Reduced
65
Closed
73

Top Buys

Rank Stock Value
1
ALKS icon
Alkermes
ALKS
+$707K
2
DVN icon
Devon Energy
DVN
+$578K
3
KMI icon
Kinder Morgan
KMI
+$529K
4
AMBA icon
Ambarella
AMBA
+$500K
5
MEDP icon
Medpace
MEDP
+$484K

Top Sells

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$1.2M
2
AAPL icon
Apple
AAPL
+$1.1M
3
MSFT icon
Microsoft
MSFT
+$1.01M
4
NVDA icon
NVIDIA
NVDA
+$996K
5
META icon
Meta Platforms (Facebook)
META
+$785K

Sector Composition

Rank Sector Weight
1 Healthcare 31.42%
2 Technology 24.96%
3 Consumer Discretionary 12.02%
4 Industrials 9.82%
5 Financials 6.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GMED icon
101
Globus Medical
GMED
$10.7B
$380K 0.47%
6,713
-11,172
-62% -$716K
TRUP icon
102
Trupanion
TRUP
$1.07B
$379K 0.46%
8,832
– –
RCUS icon
103
Arcus Biosciences
RCUS
$3.55B
$374K 0.46%
20,501
+4,344
+27% +$83K
RLAY icon
104
Relay Therapeutics
RLAY
$4.1B
$372K 0.46%
22,612
+6,184
+38% +$111K
TXG icon
105
10x Genomics
TXG
$6B
$371K 0.46%
6,655
+3,879
+140% +$181K
CRSP icon
106
CRISPR Therapeutics
CRSP
$4.73B
$371K 0.46%
+8,205
New +$399K
ACAD icon
107
Acadia Pharmaceuticals
ACAD
$4.43B
$365K 0.45%
19,372
+1,160
+6% +$22.1K
ARVN icon
108
Arvinas
ARVN
$518M
$364K 0.45%
13,319
+5,280
+66% +$167K
CERS icon
109
Cerus
CERS
$433M
$359K 0.44%
120,915
+8,081
+7% +$24.3K
FORR icon
110
Forrester Research
FORR
$223M
$355K 0.44%
10,980
-6,297
-36% -$218K
CSTL icon
111
Castle Biosciences
CSTL
$855M
$351K 0.43%
15,452
– –
CARG icon
112
CarGurus
CARG
$3.27B
$343K 0.42%
18,342
– –
NTRA icon
113
Natera
NTRA
$38.3B
$341K 0.42%
+6,135
New +$294K
ARHS icon
114
Arhaus
ARHS
$1.05B
$337K 0.41%
40,616
-34,209
-46% -$413K
AMED
115
DELISTED
Amedisys
AMED
$332K 0.41%
4,515
-2,261
-33% -$196K
EXAS
116
DELISTED
Exact Sciences
EXAS
$330K 0.4%
4,867
-1,609
-25% -$103K
IMAX icon
117
IMAX
IMAX
$2.62B
$326K 0.4%
17,018
– –
COMP icon
118
Compass
COMP
$8.51B
$326K 0.4%
+100,978
New +$346K
JJSF icon
119
J&J Snack Foods
JJSF
$1.43B
$326K 0.4%
2,198
-1,465
-40% -$213K
FNA
120
DELISTED
Paragon 28, Inc.
FNA
$319K 0.39%
18,701
+1,352
+8% +$24.1K
ALEC icon
121
Alector
ALEC
$168M
$319K 0.39%
51,465
-17,162
-25% -$140K
CNK icon
122
Cinemark Holdings
CNK
$4.24B
$316K 0.39%
21,377
– –
RPAY icon
123
Repay Holdings
RPAY
$331M
$311K 0.38%
47,347
+19,380
+69% +$160K
TDOC icon
124
Teladoc Health
TDOC
$1.22B
$309K 0.38%
11,912
+1,973
+20% +$52.8K
PNFP icon
125
Pinnacle Financial Partners Inc
PNFP
$15.9B
$306K 0.38%
5,556
– –
3 4
5
6 7

Similar funds

AI
AXS Investments Port Chester, New York $248M AUM 15.95% 1-Year Est. Return
AB
ANB Bank Denver, Colorado $247M AUM 19.59% 1-Year Est. Return
PWS
Peloton Wealth Strategists Indianapolis, Indiana $247M AUM 13.57% 1-Year Est. Return
BFM
Blacksheep Fund Management Co. Dublin, Ireland $247M AUM 8.75% 1-Year Est. Return
IFPG
Intrepid Financial Planning Group Carmel, Indiana $248M AUM 19.02% 1-Year Est. Return
SCM
Segra Capital Management Palm Beach, Florida $248M AUM 65.61% 1-Year Est. Return
GWS
Greykasell Wealth Strategies Danville, California $248M AUM 22.08% 1-Year Est. Return
MC
Mount Capital London, United Kingdom $248M AUM 4.81% 1-Year Est. Return

Capital Impact Advisors's Q1 2023 Portfolio in Review

As of Q1 2023, Capital Impact Advisors held 250 positions worth $81.5M, down 20% from $102M the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Capital Impact Advisors withdrew a net $26.6M in Q1 2023, closing 73 positions and reducing 65 holdings. Its most notable exit was Alphabet (Google) Class A, an estimated $1.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 27% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Capital Impact Advisors opened a new position in Alkermes worth $732K.

  • Capital Impact Advisors's largest Q1 2023 buy was Alkermes: 25,958 shares worth $732K.
  • Capital Impact Advisors added most to Appian in Q1 2023, an estimated $416K increase.
  • Capital Impact Advisors's biggest Q1 2023 reduction was Clean Harbors, cutting an estimated $741K.
  • Capital Impact Advisors fully exited Alphabet (Google) Class A in Q1 2023, selling an estimated $1.2M.
  • Capital Impact Advisors's ten largest holdings make up 12% of its $81.5M portfolio in Q1 2023.
  • Capital Impact Advisors opened 14 new positions and closed 73 in Q1 2023.
  • Capital Impact Advisors's portfolio value fell 20% quarter-over-quarter to $81.5M.

Based on Capital Impact Advisors's 13F filing for Q1 2023, filed 23 May 2023.